Effect of antipsychotic plus buflomedil hydrochlorde in ameliorating the negative symptoms of patients with schizophrenia

Zhong Zhi-yong,Tao Jiong,Wang Xiang-lan,Wu Xiao-li,Zhang Jin-bei
2006-01-01
Abstract:AIM: To analyze the effect of antipsychotic with the vascular activator of buflomedil hydrochlorde on the treatment of negative schizophrenia. METHODS: Sixty-eight schizophrenic patients with negative symptoms, who were hospitalized in the Department of Psychology, the Third Affiliated Hospital of Sun Yat-sen University between February 2003 and May 2004, were randomly divided into study group (n=33) and control group (n=35). All the patients were treated with atypical antipsychotic, including clozapine (400-600 mg per day), risperidone (4-6 mg per day), quetiapine (600-1000 mg per day), olanzapine (15-25 mg per day), besides those in the study group were also treated with venous drip of buflomedil hydrochlorde (150 mg per day) for 4-5 weeks, and the patients in the control group were given placebo (saline) besides antipsychotics. The changes of symptoms before and after treatment in all the patients were assessed with brief psychiatric rating scale (BPRS), scale for the assessment of negative symptoms (SANS), scale for the assessment of positive symptoms (SAPS) and treatment emergent symptom scale (TESS). The curative efficiency was evaluated by the decrease scale rating of BPRS. The decrease scale rating of BPRS = (the base score-No n score)/(the base score-18), and it was regulated that the decrease scale rating ≥75% was taken as no symptom in clinic, 50% ≤ the decrease scale rating < 75% as very much improved, 25% ≤ the decrease scale rating < 50% as much improved, and the decrease scale rating < 25% as effectless. RESULTS: All the 68 patients finished the scale assessment, and entered the results analysis. ① After treatment, the total scores of BPRS, SANS, SAPS in both the study group and control group were obviously decreased as compared with those in the control group, and those in the study group were also markedly decreased as compared with those in the control group (t=3.486, 7.970, 3.436, P=0.001, 0.000, 0.001). ② In the study group, the number of cases and percent of no symptom in clinic was 5 (15%), very much improved in 16 (48%), much improved in 8 (24%), and effectless in 4 (12%); In the control group, the above were 1 (3%), 10 (28%), 16 (46%), 8 (23%). The therapeutic effect at 4 weeks after treatment was significantly higher in the study group than in the control group (χ2=7.999, P=0.046). ③ The total score of TESS in the study group had no obvious changes as compared with that in the control group. After treatment, the main side effects in the two groups were triglyceride, increase of body mass, drowsiness and constipation, but there were no obvious differences between the two groups. CONCLUSION: For schizophrenia with negative symptoms, the treatment of antipsychotic combined with buflomedil hydrochlorde can expand the vessels at ischemic site, ameliorate blood circulation, increase the supply of oxygen and nutritions, and save and recover the neurons that are to be damaged and some already damaged ones, and then it improves the clinical effect without increasing the side effects of the antipsychotic.
What problem does this paper attempt to address?